American International Group, Inc. Neoleukin Therapeutics, Inc. Transaction History

American International Group, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.25 $16,083 - $39,334	-17,482 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $2,115 - $6,432	-1,230 Reduced 6.57%	17,482 $33,000
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.75 $2,599 - $4,332	-559 Reduced 2.9%	18,712 $90,000
Q3 2021 Nov 12, 2021	SELL	$6.05 - $9.66 $2,770 - $4,424	-458 Reduced 2.32%	19,271 $139,000
Q2 2021 Aug 13, 2021	BUY	$9.23 - $13.12 $8,805 - $12,516	954 Added 5.08%	19,729 $182,000
Q1 2021 May 07, 2021	BUY	$11.26 - $15.78 $551 - $773	49 Added 0.26%	18,775 $231,000
Q4 2020 Feb 12, 2021	SELL	$10.17 - $14.56 $5,471 - $7,833	-538 Reduced 2.79%	18,726 $264,000
Q3 2020 Nov 04, 2020	BUY	$9.68 - $17.01 $10,677 - $18,762	1,103 Added 6.07%	19,264 $231,000
Q2 2020 Aug 12, 2020	BUY	$9.95 - $17.05 $180,701 - $309,645	18,161 New	18,161 $301,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.